Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells

Area of Science:

• Immunology
• Oncology
• Cellular Biology

Background:

• The role of immune surveillance in acute lymphoblastic leukemia (ALL) is debated.
• Understanding immune evasion mechanisms in ALL is critical for effective treatment.

Purpose of the Study:

• To investigate the function of neoantigen-specific CD4+ T-cells in the ALL microenvironment.
• To elucidate the mechanism by which leukemic cells evade immune detection and promote relapse.
• To identify novel therapeutic strategies for overcoming immune suppression in ALL.

Main Methods:

• Analysis of clinical B-ALL samples.
• Development and utilization of a novel mouse model for ALL.
• Characterization of T-cell populations and their functions within the leukemia microenvironment.
• Assessment of therapeutic interventions including IL10R blockade and anti-PDL1 therapy.

Main Results:

• Neoantigen-specific CD4+ T-cells differentiate into type-1 regulatory T-cells (Tr1s) within the ALL microenvironment.
• Tr1s suppress cytotoxic CD8+ T-cell responses, hindering leukemia clearance.
• Leukemic cells mimic hematopoietic stem cells to induce Tr1s, redirecting their function from cancer prevention to promoting relapse.
• Combined anti-PDL1 therapy with cytotoxic agents eradicated measurable residual disease in mouse models.
• This therapeutic approach promoted a shift in CD4+ T-cells from Tr1 to Th1 states.

Conclusions:

• A novel mechanism of immune evasion in ALL involving Tr1-mediated suppression of anti-leukemia immunity has been identified.
• This mechanism explains the controversial role of immune surveillance in ALL and provides insight into leukemic relapse.
• Targeting Tr1 differentiation and promoting Th1 polarization represents a promising strategy to enhance immune therapies for ALL.